180 related articles for article (PubMed ID: 32331454)
1. Probing Hexaminolevulinate Mediated PpIX Fluorescence in Cancer Cell Suspensions in the Presence of Chemical Adjuvants.
Chan KM; Gleadle J; Vasilev K; MacGregor M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331454
[TBL] [Abstract][Full Text] [Related]
2. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
[TBL] [Abstract][Full Text] [Related]
3. Effects of Supplemental Drugs on Hexaminolevulinate (HAL)-Induced PpIX Fluorescence in Bladder Cancer Cell Suspensions.
Chan KM; Vasilev K; MacGregor M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886979
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract][Full Text] [Related]
5. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
7. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
[TBL] [Abstract][Full Text] [Related]
8. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
9. Protoporphyrin IX fluorescence kinetics in C6 glioblastoma cells after delta-aminolevulinic acid incubation: effect of a protoporphyrinogen oxidase inhibitor.
Carre J; Eleouet S; Rousset N; Vonarx V; Heyman D; Lajat Y; Patrice T
Cell Mol Biol (Noisy-le-grand); 1999 Jun; 45(4):433-44. PubMed ID: 10432190
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.
Kitajima Y; Ishii T; Kohda T; Ishizuka M; Yamazaki K; Nishimura Y; Tanaka T; Dan S; Nakajima M
Sci Rep; 2019 Jun; 9(1):8666. PubMed ID: 31209282
[TBL] [Abstract][Full Text] [Related]
12. Improving hexaminolevulinate enabled cancer cell detection in liquid biopsy immunosensors.
Chan KM; Gleadle J; Li J; Michl TD; Vasilev K; MacGregor M
Sci Rep; 2021 Mar; 11(1):7283. PubMed ID: 33790357
[TBL] [Abstract][Full Text] [Related]
13. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
14. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
15. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
[TBL] [Abstract][Full Text] [Related]
16. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
[TBL] [Abstract][Full Text] [Related]
17. On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation.
Collaud S; Juzeniene A; Moan J; Lange N
Curr Med Chem Anticancer Agents; 2004 May; 4(3):301-16. PubMed ID: 15134506
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
19. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
20. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
Berg K; Anholt H; Bech O; Moan J
Br J Cancer; 1996 Sep; 74(5):688-97. PubMed ID: 8795569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
